The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status

Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: Results from the 4C cohort study

(2023) Limeng Pan et al.   Journal of Diabetes Investigation

Ideal cardiovascular health and all-cause or cardiovascular mortality in a longitudinal study of the Thai National Health Examination Survey IV and V

(2023) Wichai Aekplakorn et al.   Scientific Reports

The Association of Ideal Cardiovascular Health Metrics and Incident Type 2 Diabetes Mellitus Among an urban population of Iran: a decade follow‐up in Tehran Lipid and Glucose Study

(2022) Samaneh Asgari et al.   Journal of Diabetes Investigation

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study

(2022) Farzad Hadaegh et al.   Frontiers in Cardiovascular Medicine

Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease

(2022) Zhenguo Wu et al.   Frontiers in Cardiovascular Medicine

Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study

(2022) Azra Ramezankhani et al.   Cardiovascular Diabetology

Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study

(2021) Engelbert A. Nonterah et al.   BMC Medicine

The ever‐increasing importance of cancer as a leading cause of premature death worldwide

(2021) Freddie Bray et al.   CANCER

Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review

(2021) Radu Sascău et al.   Nutrients

Further understanding of ideal cardiovascular health score metrics and cardiovascular disease

(2021) Erin D. Michos et al.   Expert Review of Cardiovascular Therapy

The burden of cardiovascular disease risk factors in the Middle East: A systematic review and meta-analysis focusing on primary prevention

(2020) Akshaya Srikanth Bhagavathula et al.   Current Vascular Pharmacology

Repositioning of the global epicentre of non-optimal cholesterol

(2020)   NATURE

New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines

(2020) Viraj Raygor et al.   Current Cardiology Reports

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank

(2019) Claire Welsh et al.   CIRCULATION

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status

(2019) Sehoon Park et al.   ANNALS OF INTERNAL MEDICINE

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

(2019) Fabian J Brunner et al.   LANCET

Risk Factors of Subclinical Atherosclerosis and Plaque Burden in High Risk Individuals: Results From a Community-Based Study

(2018) Lianduo Bian et al.   Frontiers in Physiology

Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review

(2018) Petter Bjornstad et al.   Current Diabetes Reports

Non-HDL Cholesterol and TriglyceridesHighlights

(2016) Rishi Puri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

(2016) Michael G. Silverman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia

(2016) Judit Cubedo et al.   JOURNAL OF LIPID RESEARCH

Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study

(2015) Asghar Ghasemi et al.   ACTA DIABETOLOGICA

Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study

(2014) A Mozaffary et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran

(2012) Noushin Fahimfar et al.   BMC Neurology

Hyperlipidemia as a Risk Factor for Cardiovascular Disease

(2012) Robert H. Nelson   PRIMARY CARE

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II

(2012) Fereidoun Azizi et al.   Trials

Usefulness of Insulin Resistance Estimation and the Metabolic Syndrome in Predicting Coronary Atherosclerosis in Type 2 Diabetes Mellitus

(2011) Nehal N. Mehta et al.   AMERICAN JOURNAL OF CARDIOLOGY

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

(2010) Donald M. Lloyd-Jones et al.   CIRCULATION

A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran

(2010) F Hadaegh et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

The importance of non–HDL cholesterol reporting in lipid management

(2008) Michael J. Blaha et al.   Journal of Clinical Lipidology